1 of 1
Story summary
- NRF2 influences tumor growth and chemotherapy response in non-small cell lung cancer, with implications for therapy and targeted treatment strategies.
- The c-Myc gene influences lung cancer progression and may affect tumor aggressiveness and treatment response.
- Studies compare gene expression profiling with immunohistochemistry for identifying metastatic tumors, highlighting diagnostic accuracy.
- Molecular profiling differentiates subtypes of lung adenocarcinoma, supporting refined classification and potential therapies.
